ICLRNasdaqServices-Commercial Physical & Biological Research

ICON PLC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 27, 2026

$168.14−2.04 (-1.20%)

Close on Oct 19, 2026

Margins

Share of revenue, fiscal years 2011 to 2025

26.4%−2.9 pts over 5 years

5.4%−8.6 pts over 5 years

2.8%−9.1 pts over 5 years

Compound annual growth to fiscal 2025

Per year	1 year	3 years	5 years	10 years
Revenue	+0.8%	+2.1%	+24.2%	+18.0%
Gross profit	-8.2%	-0.6%	+21.6%	+12.6%
Operating income	-57.1%	-17.7%	+2.5%	+4.6%
Net income	-69.0%	-23.2%	-7.2%	-0.4%
EPS, diluted	-67.4%	-22.1%	-14.0%	-3.1%
Free cash flow	-22.9%	+27.0%	+10.3%	+14.2%

10 fiscal years. Hover a measure to see how it is calculated.

Measure	FY2016	FY2020	FY2025
Return on equity	30.7%	19.2%	2.5%
Return on assets	14.8%	10.5%	1.4%
Current ratio	1.94	1.87	1.10
Debt to equity	–	0.19	0.31
Net debt to EBITDA	–	-1.07×	2.69×
Interest coverage	24.0×	30.1×	2.2×
Inventory turnover	457.8×	495.0×	–
Capex to revenue	2.6%	1.5%	2.1%
Diluted shares	56M	53M	79M

Return on equity split into margin, efficiency and leverage

Net margin2.8%

Asset turnover0.50×

Equity multiplier1.77×

Return on equity, FY20252.5%

Fiscal year	Net margin	Asset turnover	Equity multiplier	Return on equity
FY2025	2.8%	0.50×	1.77×	2.5%
FY2024	9.0%	0.49×	1.80×	7.9%
FY2023	6.9%	0.47×	1.92×	6.2%
FY2022	6.5%	0.45×	2.08×	6.1%
FY2021	2.8%	0.53×	2.10×	3.1%
FY2020	11.9%	0.88×	1.83×	19.2%
FY2019	13.3%	1.07×	1.77×	25.2%
FY2018	12.4%	1.15×	1.77×	25.4%
FY2017	16.0%	0.89×	1.86×	26.4%
FY2016	15.7%	0.94×	2.07×	30.7%